Iradimed (IRMD) Free Cash Flow Growth (1y) (2014 - 2026)
Powered by 
Analysis
Iradimed (IRMD) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | 12.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.60% |
| Mar 31, 2026 | 1,225.55% |
| Dec 31, 2025 | 76.08% |
| Sep 30, 2025 | 10.21% |
| Jun 30, 2025 | -7.14% |
| Mar 31, 2025 | -83.53% |
| Dec 31, 2024 | -5.45% |
| Sep 30, 2024 | 389.19% |
| Jun 30, 2024 | 66.33% |
| Mar 31, 2024 | 306.45% |
| Dec 31, 2023 | 19.65% |
| Sep 30, 2023 | -69.66% |
| Jun 30, 2023 | 135.47% |
| Mar 31, 2023 | -247.68% |
| Dec 31, 2022 | -13.73% |
| Sep 30, 2022 | 10.77% |
| Jun 30, 2022 | -59.41% |
| Mar 31, 2022 | 46.14% |
| Dec 31, 2021 | 36.33% |
| Sep 30, 2021 | 151.08% |